News

PDS Biotechnology Corporation (NASDAQ:PDSB) unveiled compelling new data on its Versamune HPV (PDS0101) immunotherapy at the ...
A grantee of the Gates Foundation, Hong Kong-based Phase Scientific built a business on the back of Covid-19 tests. Up next: ...
Dr. D. Wade Clapp's work with British biotech company Healx dates to 2019. Photo by Liz Kaye, Indiana University Indiana ...
A recovery from this prolonged and painful market downturn will require a major attitude adjustment from biotech management ...
Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...
At the recent F&A Next conference in Wageningen, the Feike Sijbesma Sustainable Innovation Award 2025 was granted to two ...
AmplifyBio said in a statement April 4, saying the decision to close followed months of efforts to keep the four-year-old ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...
The Trump administration has revoked a $44 million dollar grant intended for the Birmingham area to bolster Biotechnology ...
The Beachwood-based company announced on Tuesday, May 20, that it has appointed Dr. David Llewellyn as its new CEO and as a ...
Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...